CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack

Consultation comments and responses (PDF 433 KB)

Committee papers (PDF 400 KB)

Equality impact assessment (downloadable version) (PDF 193 KB)

Diagnostics consultation: 2

Consultation comments and responses (PDF 1.29 MB)

Diagnostics consultation document (PDF) (PDF 331 KB)

Diagnostics consultation document (Online commenting)

Diagnostics assessment report addendum 1 (PDF 2.68 MB)

Diagnostics assessment report addendum 2 (PDF 546 KB)

Diagnostics consultation: 1

Diagnostics assessment report (PDF 8.3 MB)

Overview (PDF 564 KB)

DAR Erratum (PDF 541 KB)

Consultation comments and responses (PDF 500 KB)

Diagnostics consultation document (PDF) (PDF 273 KB)

Diagnostics consultation document (Online commenting)

Register of interests - Standing committee members (PDF 220 KB)

Register of interests - Specialist committee members (PDF 265 KB)

Stakeholder list (PDF 90 KB)

Final scope (PDF 454 KB)

Equality impact assessment (PDF 163 KB)

Stakeholder list (PDF 88 KB)

Final protocol (PDF 922 KB)

Specialist committee members (PDF 119 KB)

Stakeholder list (PDF 90 KB)

Topic description (MSWord 21 KB)